Microbot Medical Files 8-K
Ticker: MBOT · Form: 8-K · Filed: Aug 1, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Aug 1, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Microbot Medical filed an 8-K, but no juicy details yet.
AI Summary
Microbot Medical Inc. filed an 8-K on August 1, 2024, reporting on other events and financial statements. The filing does not contain specific financial figures or details about the 'other events' in the provided text.
Why It Matters
This filing indicates a regulatory update from Microbot Medical Inc., but lacks specific details on the nature of the events or financial information disclosed.
Risk Assessment
Risk Level: low — The filing is a standard 8-K without immediate negative or positive financial implications mentioned.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- August 1, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 000-19871 (filing_id) — Commission File Number
- 94-3078125 (tax_id) — IRS Employer Identification No.
- 288 Grove Street , Suite 388 Braintree , MA 02184 (address) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Microbot Medical Inc.?
The 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on August 1, 2024.
In which state is Microbot Medical Inc. incorporated?
Microbot Medical Inc. is incorporated in Delaware.
What is the principal executive office address for Microbot Medical Inc.?
The principal executive office address is 288 Grove Street, Suite 388, Braintree, MA 02184.
Does this filing provide specific financial details or information about the 'Other Events'?
The provided text of the filing indicates that 'Other Events' and 'Financial Statements and Exhibits' are items being reported, but it does not contain specific financial figures or details about these events.
Filing Stats: 786 words · 3 min read · ~3 pages · Grade level 12.7 · Accepted 2024-08-01 08:30:27
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-029869.txt ( ) — 237KB
- mbot-20240801.xsd (EX-101.SCH) — 3KB
- mbot-20240801_lab.xml (EX-101.LAB) — 33KB
- mbot-20240801_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01 of this Current Report on Form 8-K contains "forward-looking statements." Such statements which are not purely
Item 8.01 of this Current Report on Form 8-K contains "forward-looking statements." Such statements which are not purely historical (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "intends," "would," "could" and "estimates") are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, regulatory milestones. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this Form 8-K, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Although the Company believes that the beliefs, plans, expectations and intentions contained in this Form 8-K are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the Company's reports and statements filed from time-to-time with the Securities and Exchange Commission. Item 9.01. Financial (d) Exhibits Exhibit Number Description 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: August 1, 2024